Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

The role of CD30 and CD153 (CD30L) in the anti-mycobacterial immune response.

Marín ND, García LF.

Tuberculosis (Edinb). 2017 Jan;102:8-15. doi: 10.1016/j.tube.2016.10.006. Epub 2016 Nov 1. Review.

PMID:
28061955
2.

A CD153+CD4+ T follicular cell population with cell-senescence features plays a crucial role in lupus pathogenesis via osteopontin production.

Tahir S, Fukushima Y, Sakamoto K, Sato K, Fujita H, Inoue J, Uede T, Hamazaki Y, Hattori M, Minato N.

J Immunol. 2015 Jun 15;194(12):5725-35. doi: 10.4049/jimmunol.1500319. Epub 2015 May 13.

3.

CD153 in rheumatoid arthritis: detection of a soluble form in serum and synovial fluid, and expression by mast cells in the rheumatic synovium.

Carvalho RF, Ulfgren AK, Engström M, Klint Ea, Nilsson G.

J Rheumatol. 2009 Mar;36(3):501-7. doi: 10.3899/jrheum.080288. Epub 2009 Jan 22.

PMID:
19208589
4.

Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma.

Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Nilsson G, Harvima IT.

Cancer Immunol Immunother. 2007 Sep;56(9):1407-15. Epub 2007 Feb 1.

PMID:
17268792
5.

CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.

Blazar BR, Levy RB, Mak TW, Panoskaltsis-Mortari A, Muta H, Jones M, Roskos M, Serody JS, Yagita H, Podack ER, Taylor PA.

J Immunol. 2004 Sep 1;173(5):2933-41.

6.

Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.

Flórido M, Borges M, Yagita H, Appelberg R.

J Leukoc Biol. 2004 Nov;76(5):1039-46. Epub 2004 Aug 17.

PMID:
15316035
7.

CD27/CD70, CD134/CD134 ligand, and CD30/CD153 pathways are independently essential for generation of regulatory cells after intratracheal delivery of alloantigen.

Aramaki O, Shirasugi N, Akiyama Y, Shibutani S, Takayama T, Shimazu M, Kitajima M, Ikeda Y, Okumura K, Yagita H, Niimi M.

Transplantation. 2003 Sep 15;76(5):772-6.

PMID:
14501851
9.

Characterization of the murine CD30 ligand (CD153) gene: gene structure and expression.

Goldie-Cregan LC, Croager EJ, Abraham LJ.

Tissue Antigens. 2002 Aug;60(2):139-46.

PMID:
12392508
10.

Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30.

Hargreaves PG, Al-Shamkhani A.

Eur J Immunol. 2002 Jan;32(1):163-73.

11.

Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.

Cerutti A, Schaffer A, Goodwin RG, Shah S, Zan H, Ely S, Casali P.

J Immunol. 2000 Jul 15;165(2):786-94.

12.

CD153.

Armitage RJ.

J Biol Regul Homeost Agents. 2000 Apr-Jun;14(2):142-4. No abstract available.

PMID:
10841292
13.

Expression of CD30 ligand (CD153) on murine activated T cells.

Shimozato O, Takeda K, Yagita H, Okumura K.

Biochem Biophys Res Commun. 1999 Mar 24;256(3):519-26.

PMID:
10080930

Supplemental Content

Support Center